CYTOKINETICS INC — Director's Dealing 2010

Jan 4, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2010-01-04

Reporting Person: HEIDRICH A GRANT III (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2010-01-04	Stock Option (right to buy)	$3.11	A	16077	Acquired	2020-01-04	Common Stock (16077)	Direct

Footnotes

F1: The option shall vest and become exercisable in equal monthly installments such that the option shall be 100% vested on January 4, 2011.

F2: This option was issued to the Reporting Person pursuant to the Cytokinetics 2004 Equity Incentive Plan in lieu of an annual retainer of $20,000.